Last 12 months
Inside the activity.
4 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 3 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 1 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 22, 2023 Filed Aug 24, 2023 21:21 UTC |
Shah DharmeshDirector · Chief Technology Officer
|
SaleCommon Stock | 1,590 | $509.47 | $810,057.30 |
DisclosureSEC source: 0001209191-23-047223 · doc4.xml · nonDerivative · entry 9 Shah Dharmesh · CIK 0001620814 · Director · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,411,114 F1 · kind: This transaction was effected pursuant to a written trading plan adopted by the Reporting Person on 5/17/2023 in accordance with Rule 10b5-1. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.97 to $509.86, inclusive. The reporting person undertakes to provide to HubSpot, Inc., any security holder of HubSpot, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (10) herein. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 21:21 UTC |
Shah DharmeshDirector · Chief Technology Officer
|
SaleCommon Stock | 1,744 | $508.17 | $886,248.48 |
DisclosureSEC source: 0001209191-23-047223 · doc4.xml · nonDerivative · entry 8 Shah Dharmesh · CIK 0001620814 · Director · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,412,704 F1 · kind: This transaction was effected pursuant to a written trading plan adopted by the Reporting Person on 5/17/2023 in accordance with Rule 10b5-1. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $507.90 to $508.75, inclusive. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 21:21 UTC |
Shah DharmeshDirector · Chief Technology Officer
|
SaleCommon Stock | 3,774 | $507.25 | $1,914,361.50 |
DisclosureSEC source: 0001209191-23-047223 · doc4.xml · nonDerivative · entry 7 Shah Dharmesh · CIK 0001620814 · Director · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,414,448 F1 · kind: This transaction was effected pursuant to a written trading plan adopted by the Reporting Person on 5/17/2023 in accordance with Rule 10b5-1. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $506.82 to $507.79, inclusive. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 21:21 UTC |
Shah DharmeshDirector · Chief Technology Officer
|
SaleCommon Stock | 3,007 | $506.46 | $1,522,925.22 |
DisclosureSEC source: 0001209191-23-047223 · doc4.xml · nonDerivative · entry 6 Shah Dharmesh · CIK 0001620814 · Director · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,418,222 F1 · kind: This transaction was effected pursuant to a written trading plan adopted by the Reporting Person on 5/17/2023 in accordance with Rule 10b5-1. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $505.82 to $506.80, inclusive. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 21:21 UTC |
Shah DharmeshDirector · Chief Technology Officer
|
SaleCommon Stock | 2,742 | $505.33 | $1,385,614.86 |
DisclosureSEC source: 0001209191-23-047223 · doc4.xml · nonDerivative · entry 5 Shah Dharmesh · CIK 0001620814 · Director · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,421,229 F1 · kind: This transaction was effected pursuant to a written trading plan adopted by the Reporting Person on 5/17/2023 in accordance with Rule 10b5-1. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $504.76 to $505.75, inclusive. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 21:21 UTC |
Shah DharmeshDirector · Chief Technology Officer
|
SaleCommon Stock | 3,466 | $504.10 | $1,747,210.60 |
DisclosureSEC source: 0001209191-23-047223 · doc4.xml · nonDerivative · entry 4 Shah Dharmesh · CIK 0001620814 · Director · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,423,971 F1 · kind: This transaction was effected pursuant to a written trading plan adopted by the Reporting Person on 5/17/2023 in accordance with Rule 10b5-1. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $503.76 to $504.70, inclusive. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 21:21 UTC |
Shah DharmeshDirector · Chief Technology Officer
|
SaleCommon Stock | 1,100 | $503.49 | $553,839.00 |
DisclosureSEC source: 0001209191-23-047223 · doc4.xml · nonDerivative · entry 3 Shah Dharmesh · CIK 0001620814 · Director · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,427,437 F1 · kind: This transaction was effected pursuant to a written trading plan adopted by the Reporting Person on 5/17/2023 in accordance with Rule 10b5-1. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $502.76 to $503.75, inclusive. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 21:21 UTC |
Shah DharmeshDirector · Chief Technology Officer
|
SaleCommon Stock | 1,815 | $502.09 | $911,293.35 |
DisclosureSEC source: 0001209191-23-047223 · doc4.xml · nonDerivative · entry 2 Shah Dharmesh · CIK 0001620814 · Director · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,428,537 F1 · kind: This transaction was effected pursuant to a written trading plan adopted by the Reporting Person on 5/17/2023 in accordance with Rule 10b5-1. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $501.60 to $502.50, inclusive. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 21:21 UTC |
Shah DharmeshDirector · Chief Technology Officer
|
SaleCommon Stock | 662 | $500.81 | $331,536.22 |
DisclosureSEC source: 0001209191-23-047223 · doc4.xml · nonDerivative · entry 1 Shah Dharmesh · CIK 0001620814 · Director · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,430,352 F1 · kind: This transaction was effected pursuant to a written trading plan adopted by the Reporting Person on 5/17/2023 in accordance with Rule 10b5-1. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $500.55 to $501.53, inclusive. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 23:46 UTC |
Bueker KathrynChief Financial Officer
|
SaleCommon Stock | 918 | $507.76 | $466,123.68 |
DisclosureSEC source: 0001209191-23-046133 · doc4.xml · nonDerivative · entry 1 Bueker Kathryn · CIK 0001741660 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,106 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 2/23/2023. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 23:48 UTC |
Shah DharmeshDirector · Chief Technology Officer
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-046138 · doc4.xml · nonDerivative · entry 1 Shah Dharmesh · CIK 0001620814 · Director · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,431,014 F1 · shares: Represents shares of the Issuer's common stock donated as a gift by the reporting person to the Humani Foundation, a charitable foundation. The reporting person is deemed to have voting and investment power over the shares of the Issuer's common stock held by the Humani Foundation, but has no pecuniary interest in these shares. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 23:47 UTC |
Halligan BrianDirector · Executive Chair
|
SaleCommon Stock | 8,500 | $507.76 | $4,315,960.00 |
DisclosureSEC source: 0001209191-23-046136 · doc4.xml · nonDerivative · entry 1 Halligan Brian · CIK 0001603527 · Director · Executive Chair 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 578,376 F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 3/13/2023. Read SEC document |
| August 02, 2023 Filed Aug 3, 2023 20:20 UTC |
Harvey Dawson AlyssaChief Legal Officer
|
SaleCommon Stock | 766 | $569.43 | $436,183.38 |
DisclosureSEC source: 0001209191-23-044435 · doc4.xml · nonDerivative · entry 1 Harvey Dawson Alyssa · CIK 0001891831 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,062 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 2/23/2023. Read SEC document |
| August 01, 2023 Filed Aug 2, 2023 20:09 UTC |
Harvey Dawson AlyssaChief Legal Officer
|
Tax withholdingCommon Stock | 664 | $576.36 | $382,703.04 |
DisclosureSEC source: 0001209191-23-044189 · doc4.xml · nonDerivative · entry 1 Harvey Dawson Alyssa · CIK 0001891831 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,828 F1 · kind: Shares withheld by Issuer to cover taxes associated with settlement of restricted stock units. F2 · balance_after: Includes 121 shares purchased under the Issuer's employee stock purchase plan on June 1, 2023. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 21:39 UTC |
Halligan BrianDirector · Executive Chair
|
SaleCommon Stock | 8,500 | $556.69 | $4,731,865.00 |
DisclosureSEC source: 0001209191-23-042770 · doc4.xml · nonDerivative · entry 1 Halligan Brian · CIK 0001603527 · Director · Executive Chair 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 586,876 F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 3/13/2023. Read SEC document |
| July 13, 2023 Filed Jul 14, 2023 20:08 UTC |
Bueker KathrynChief Financial Officer
|
SaleCommon Stock | 300 | $550.00 | $165,000.00 |
DisclosureSEC source: 0001209191-23-042262 · doc4.xml · nonDerivative · entry 1 Bueker Kathryn · CIK 0001741660 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,024 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 2/23/2023. Read SEC document |
| July 05, 2023 Filed Jul 6, 2023 20:58 UTC |
Rangan YaminiDirector · Chief Executive Officer & Pres
|
SaleCommon Stock | 3,136 | $519.62 | $1,629,528.32 |
DisclosureSEC source: 0001209191-23-041581 · doc4.xml · nonDerivative · entry 1 Rangan Yamini · CIK 0001753409 · Director · Chief Executive Officer & Pres 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,519 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 3/9/2023. Read SEC document |
| July 05, 2023 Filed Jul 6, 2023 20:57 UTC |
Bueker KathrynChief Financial Officer
|
SaleCommon Stock | 782 | $519.62 | $406,342.84 |
DisclosureSEC source: 0001209191-23-041579 · doc4.xml · nonDerivative · entry 1 Bueker Kathryn · CIK 0001741660 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,324 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 2/23/2023. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 01:10 UTC |
Rangan YaminiDirector · Chief Executive Officer & Pres
|
Tax withholdingCommon Stock | 3,146 | $526.27 | $1,655,645.42 |
DisclosureSEC source: 0001209191-23-041401 · doc4.xml · nonDerivative · entry 1 Rangan Yamini · CIK 0001753409 · Director · Chief Executive Officer & Pres 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,655 F1 · kind: Shares withheld by Issuer to cover taxes associated with settlement of restricted stock units. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 01:01 UTC |
Bueker KathrynChief Financial Officer
|
Tax withholdingCommon Stock | 986 | $526.27 | $518,902.22 |
DisclosureSEC source: 0001209191-23-041384 · doc4.xml · nonDerivative · entry 1 Bueker Kathryn · CIK 0001741660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,106 F1 · kind: Shares withheld by Issuer to cover taxes associated with settlement of restricted stock units. F2 · balance_after: Includes 65 shares purchased under the Issuer's employee stock purchase plan on June 1, 2023. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 01:06 UTC |
Shah DharmeshDirector · Chief Technology Officer
|
Tax withholdingCommon Stock | 632 | $526.27 | $332,602.64 |
DisclosureSEC source: 0001209191-23-041390 · doc4.xml · nonDerivative · entry 1 Shah Dharmesh · CIK 0001620814 · Director · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,441,014 F1 · kind: Shares withheld by Issuer to cover taxes associated with settlement of restricted stock units. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 01:09 UTC |
Halligan BrianDirector · Executive Chair
|
Tax withholdingCommon Stock | 974 | $526.27 | $512,586.98 |
DisclosureSEC source: 0001209191-23-041396 · doc4.xml · nonDerivative · entry 1 Halligan Brian · CIK 0001603527 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 595,376 F1 · kind: Shares withheld by Issuer to cover taxes associated with settlement of restricted stock units. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 20:07 UTC |
Halligan BrianDirector · Executive Chair
|
SaleCommon Stock | 8,500 | $513.78 | $4,367,130.00 |
DisclosureSEC source: 0001209191-23-038763 · doc4.xml · nonDerivative · entry 1 Halligan Brian · CIK 0001603527 · Director · Executive Chair 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 596,350 F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 3/13/2023. Read SEC document |
| June 12, 2023 Filed Jun 13, 2023 20:20 UTC |
Rangan YaminiDirector · Chief Executive Officer & Pres
|
SaleCommon Stock | 10,846 | $516.83 | $5,605,538.18 |
DisclosureSEC source: 0001209191-23-036667 · doc4.xml · nonDerivative · entry 1 Rangan Yamini · CIK 0001753409 · Director · Chief Executive Officer & Pres 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,801 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 3/9/2023. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:01 UTC |
Simons JayDirector
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $464.88 | $0.00 |
DisclosureSEC source: 0001209191-23-035204 · doc4.xml · derivative · entry 2 Simons Jay · CIK 0001695216 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F2 · derivative.exercise_date: This stock option vests in equal quarterly installments over a one-year period from June 5, 2023 (date of grant), with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:01 UTC |
Simons JayDirector
|
GrantCommon Stock | 322 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035204 · doc4.xml · nonDerivative · entry 1 Simons Jay · CIK 0001695216 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,430 F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2014 Stock Option and Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Company's Common Stock. The restricted stock unit will vest in equal quarterly installments over a one-year period from the date of grant, with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:54 UTC |
Gill Ronald SDirector
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $464.88 | $0.00 |
DisclosureSEC source: 0001209191-23-035192 · doc4.xml · derivative · entry 2 Gill Ronald S · CIK 0001494474 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F2 · derivative.exercise_date: This stock option vests in equal quarterly installments over a one-year period from June 5, 2023 (date of grant), with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:54 UTC |
Gill Ronald SDirector
|
GrantCommon Stock | 322 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035192 · doc4.xml · nonDerivative · entry 1 Gill Ronald S · CIK 0001494474 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,042 F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2014 Stock Option and Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Company's Common Stock. The restricted stock unit will vest in equal quarterly installments over a one-year period from the date of grant, with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:02 UTC |
Ward Jill ADirector
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $464.88 | $0.00 |
DisclosureSEC source: 0001209191-23-035209 · doc4.xml · derivative · entry 2 Ward Jill A · CIK 0001257774 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F2 · derivative.exercise_date: This stock option vests in equal quarterly installments over a one-year period from June 5, 2023 (date of grant), with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:02 UTC |
Ward Jill ADirector
|
GrantCommon Stock | 322 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035209 · doc4.xml · nonDerivative · entry 1 Ward Jill A · CIK 0001257774 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,767 F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2014 Stock Option and Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Company's Common Stock. The restricted stock unit will vest in equal quarterly installments over a one-year period from the date of grant, with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:00 UTC |
Sahai AvanishDirector
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $464.88 | $0.00 |
DisclosureSEC source: 0001209191-23-035201 · doc4.xml · derivative · entry 2 Sahai Avanish · CIK 0001737993 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F2 · derivative.exercise_date: This stock option vests in equal quarterly installments over a one-year period from June 5, 2023 (date of grant), with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:00 UTC |
Sahai AvanishDirector
|
GrantCommon Stock | 322 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035201 · doc4.xml · nonDerivative · entry 1 Sahai Avanish · CIK 0001737993 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,885 F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2014 Stock Option and Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Company's Common Stock. The restricted stock unit will vest in equal quarterly installments over a one-year period from the date of grant, with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:59 UTC |
NORRINGTON LORRIE MDirector
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $464.88 | $0.00 |
DisclosureSEC source: 0001209191-23-035197 · doc4.xml · derivative · entry 2 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F2 · derivative.exercise_date: This stock option vests in equal quarterly installments over a one-year period from June 5, 2023 (date of grant), with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:59 UTC |
NORRINGTON LORRIE MDirector
|
GrantCommon Stock | 322 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035197 · doc4.xml · nonDerivative · entry 1 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,207 F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2014 Stock Option and Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Company's Common Stock. The restricted stock unit will vest in equal quarterly installments over a one-year period from the date of grant, with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 20:18 UTC |
Caldwell Nick V.Director
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $464.88 | $0.00 |
DisclosureSEC source: 0001209191-23-035072 · doc4.xml · derivative · entry 2 Caldwell Nick V. · CIK 0001838934 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F2 · derivative.exercise_date: This stock option vests in equal quarterly installments over a one-year period from June 5, 2023 (date of grant), with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 20:18 UTC |
Caldwell Nick V.Director
|
GrantCommon Stock | 322 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035072 · doc4.xml · nonDerivative · entry 1 Caldwell Nick V. · CIK 0001838934 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,303 F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2014 Stock Option and Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Company's Common Stock. The restricted stock unit will vest in equal quarterly installments over a one-year period from the date of grant, with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 8, 2023 14:19 UTC |
Johnson Claire D'Oyly-HughesDirector
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $464.88 | $0.00 |
DisclosureSEC source: 0001209191-23-035277 · doc4.xml · derivative · entry 2 Johnson Claire D'Oyly-Hughes · CIK 0001874135 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F2 · derivative.exercise_date: This stock option vests in equal quarterly installments over a one-year period from June 5, 2023 (date of grant), with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Jun 8, 2023 14:19 UTC |
Johnson Claire D'Oyly-HughesDirector
|
GrantCommon Stock | 322 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035277 · doc4.xml · nonDerivative · entry 1 Johnson Claire D'Oyly-Hughes · CIK 0001874135 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 816 F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2014 Stock Option and Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Company's Common Stock. The restricted stock unit will vest in equal quarterly installments over a one-year period from the date of grant, with the final installment vesting upon the first anniversary of such grant date (or, if earlier, immediately prior to the 2024 annual meeting of stockholders). Read SEC document |
| June 05, 2023 Filed Aug 19, 2024 20:46 UTC Amendment |
Simons JayDirector
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $528.59 | $0.00 |
DisclosureSEC source: 0000950170-24-098615 · ownership.xml · derivative · entry 3 Simons Jay · CIK 0001695216 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F5 · derivative.exercise_price: The original Form 4 filed on June 7, 2023 is being amended by this Form 4 amendment to correct the price reported in column 2 of Table II in the original Form 4, which inadvertently included the incorrect price. All other information reported in the original Form 4 is correct. F6 · derivative.exercise_date: This stock option was scheduled to vest in full on the one year anniversary of the date of grant (or, if earlier, immediately prior to the 2024 annual meeting of stockholders), and vested in full on June 5, 2024. Read SEC document |
| June 05, 2023 Filed Aug 19, 2024 21:01 UTC Amendment |
Gill Ronald SDirector
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $528.59 | $0.00 |
DisclosureSEC source: 0000950170-24-098653 · ownership.xml · derivative · entry 3 Gill Ronald S · CIK 0001494474 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F5 · derivative.exercise_price: The original Form 4 filed on June 7, 2023 is being amended by this Form 4 amendment to correct the price reported in column 2 of Table II in the original Form 4, which inadvertently included the incorrect price. All other information reported in the original Form 4 is correct. F6 · derivative.exercise_date: This stock option was scheduled to vest in full on the one year anniversary of the date of grant (or, if earlier, immediately prior to the 2024 annual meeting of stockholders), and vested in full on June 5, 2024. Read SEC document |
| June 05, 2023 Filed Aug 19, 2024 21:05 UTC Amendment |
Johnson Claire D'Oyly-HughesDirector
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $528.59 | $0.00 |
DisclosureSEC source: 0000950170-24-098662 · ownership.xml · derivative · entry 1 Johnson Claire D'Oyly-Hughes · CIK 0001874135 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F1 · derivative.exercise_price: The original Form 4 filed on June 8, 2023 is being amended by this Form 4 amendment to correct the price reported in column 2 of Table II in the original Form 4, which inadvertently included the incorrect price. All other information reported in the original Form 4 is correct. F2 · derivative.exercise_date: This stock option was scheduled to vest in full on the one year anniversary of the date of grant (or, if earlier, immediately prior to the 2024 annual meeting of stockholders), and vested in full on June 5, 2024. Read SEC document |
| June 05, 2023 Filed Aug 19, 2024 20:57 UTC Amendment |
Caldwell Nick V.Director
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $528.59 | $0.00 |
DisclosureSEC source: 0000950170-24-098636 · ownership.xml · derivative · entry 2 Caldwell Nick V. · CIK 0001838934 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F3 · derivative.exercise_price: The original Form 4 filed on June 7, 2023 is being amended by this Form 4 amendment to correct the price reported in column 2 of Table II in the original Form 4, which inadvertently included the incorrect price. All other information reported in the original Form 4 is correct. F4 · derivative.exercise_date: 4. This stock option was scheduled to vest in full on the one year anniversary of the date of grant (or, if earlier, immediately prior to the 2024 annual meeting of stockholders), and vested in full on June 5, 2024. Read SEC document |
| June 05, 2023 Filed Aug 19, 2024 20:49 UTC Amendment |
Ward Jill ADirector
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $528.59 | $0.00 |
DisclosureSEC source: 0000950170-24-098618 · ownership.xml · derivative · entry 3 Ward Jill A · CIK 0001257774 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F5 · derivative.exercise_price: The original Form 4 filed on June 7, 2023 is being amended by this Form 4 amendment to correct the price reported in column 2 of Table II in the original Form 4, which inadvertently included the incorrect price. All other information reported in the original Form 4 is correct. F6 · derivative.exercise_date: This stock option was scheduled to vest in full on the one year anniversary of the date of grant (or, if earlier, immediately prior to the 2024 annual meeting of stockholders), and vested in full on June 5, 2024. Read SEC document |
| June 05, 2023 Filed Aug 19, 2024 20:44 UTC Amendment |
NORRINGTON LORRIE MDirector
|
GrantStock Option (right to buy) · Derivative | 204 | $0.00 Strike: $528.59 | $0.00 |
DisclosureSEC source: 0000950170-24-098609 · ownership.xml · derivative · entry 2 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires 2033-06-05 F3 · derivative.exercise_price: The original Form 4 filed on June 7, 2023 is being amended by this Form 4 amendment to correct the price reported in column 2 of Table II in the original Form 4, which inadvertently included the incorrect price. All other information reported in the original Form 4 is correct. F4 · derivative.exercise_date: This stock option was scheduled to vest in full on the one year anniversary of the date of grant (or, if earlier, immediately prior to the 2024 annual meeting of stockholders), and vested in full on June 5, 2024. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:01 UTC |
Rangan YaminiDirector · Chief Executive Officer & Pres
|
Tax withholdingCommon Stock | 120 | $517.79 | $62,134.80 |
DisclosureSEC source: 0001209191-23-033883 · doc4.xml · nonDerivative · entry 1 Rangan Yamini · CIK 0001753409 · Director · Chief Executive Officer & Pres 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,647 F1 · kind: Shares withheld by Issuer to cover taxes associated with settlement of restricted stock units. Read SEC document |
| May 26, 2023 Filed May 30, 2023 20:21 UTC |
Bueker KathrynChief Financial Officer
|
SaleCommon Stock | 406 | $500.00 | $203,000.00 |
DisclosureSEC source: 0001209191-23-032877 · doc4.xml · nonDerivative · entry 1 Bueker Kathryn · CIK 0001741660 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,027 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 2/23/2023. Read SEC document |
| May 26, 2023 Filed May 30, 2023 20:23 UTC |
Harvey Dawson AlyssaChief Legal Officer
|
SaleCommon Stock | 595 | $500.00 | $297,500.00 |
DisclosureSEC source: 0001209191-23-032880 · doc4.xml · nonDerivative · entry 2 Harvey Dawson Alyssa · CIK 0001891831 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,371 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 2/23/2023. Read SEC document |
| May 26, 2023 Filed May 30, 2023 20:23 UTC |
Harvey Dawson AlyssaChief Legal Officer
|
SaleCommon Stock | 1,789 | $490.42 | $877,361.38 |
DisclosureSEC source: 0001209191-23-032880 · doc4.xml · nonDerivative · entry 1 Harvey Dawson Alyssa · CIK 0001891831 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,966 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 2/23/2023. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:21 UTC |
Bueker KathrynChief Financial Officer
|
SaleCommon Stock | 691 | $492.31 | $340,186.21 |
DisclosureSEC source: 0001209191-23-031884 · doc4.xml · nonDerivative · entry 1 Bueker Kathryn · CIK 0001741660 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,433 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 2/23/2023. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:06 UTC |
Shah DharmeshDirector · Chief Technology Officer
|
Tax withholdingCommon Stock | 113 | $459.71 | $51,947.23 |
DisclosureSEC source: 0001209191-23-030139 · doc4.xml · nonDerivative · entry 1 Shah Dharmesh · CIK 0001620814 · Director · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,441,646 F1 · kind: Shares withheld by Issuer to cover taxes associated with settlement of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.